Comments
Loading...
Annabidiol Analyst Ratings and Price Targets | OTC:ACBD | Benzinga
Annabidiol Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Annabidiol Corp from these most-recent analyst ratings.
Analyst Ratings for Annabidiol
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Annabidiol (ACBD) stock?
There is no price target for Annabidiol
What is the most recent analyst rating for Annabidiol (ACBD)?
There is no analyst for Annabidiol
When was the last upgrade for Annabidiol (ACBD)?
There is no last upgrade for Annabidiol
When was the last downgrade for Annabidiol (ACBD)?
There is no last downgrade for Annabidiol.
When is the next analyst rating going to be posted or updated for Annabidiol (ACBD)?
There is no next analyst rating for Annabidiol.
Is the Analyst Rating Annabidiol (ACBD) correct?
There is no next analyst rating for Annabidiol.
Browse analyst ratings and price targets on all stocks.
